Maximize Your Impact at Biomarkers & Precision Medicine US 2025
Biomarkers & Precision Medicine US 2025, taking place on October 27 at the Westin St. Francis San Francisco, brings together top decision-makers from the biopharma, diagnostic, and healthcare sectors. This conference has become a central meeting point for clinical development leaders, translational scientists, and commercialization teams focused on precision diagnostics and targeted therapies.
Attendees are actively engaged in making decisions that influence research partnerships, biomarker discovery platforms, and investment in next-generation diagnostics. Many come with current mandates to evaluate new technologies, close vendor agreements, and initiate collaborations to support progression from early discovery to patient impact.
Executives attending this event typically represent mid-to-senior leadership across R&D, clinical operations, business development, and therapeutic strategy. For commercial teams, this means a concentrated opportunity to connect with professionals who have both budget authority and specific, time-sensitive priorities. With the enriched Vendelux attendee list, you’ll have insight into who’s attending, what their function is, and which organizations are positioned for strategic outreach ahead of the event.
How Sales, Marketing and Revops Teams Can Use This Attendee List
This conference attracts stakeholders looking to accelerate time-to-market for precision medicine solutions. If your company provides biomarker validation tools, data analytics platforms, CRO services, or clinical trial solutions, the attendee data becomes a resource to sharpen your targeting and messaging.
Segment your outreach by roles such as heads of translational medicine, biomarker R&D leads, or diagnostic innovation directors to reflect the attendee’s real workload and challenges. Use company types—whether large pharmaceutical firms or emerging biotech startups—to adapt your value proposition and cadence.
Booking meetings in advance matters at this conference because attendees often arrive with packed agendas. The enriched attendee list gives you verified contact information, titles, and LinkedIn profiles so you can reach decision-makers weeks early and enter the event with scheduled conversations in place.
After the event, follow up with touchpoints tied to therapeutic areas discussed at the conference, recent biomarker approvals, or ongoing trial needs. Referencing session topics or industry pain points shows alignment and moves relationships forward beyond the show floor.
Vendelux helps you understand how to get more meetings with the right stakeholders by offering enriched conference attendee list data that turns event participation into sales traction.
Timing Is Everything
Biomarkers & Precision Medicine US 2025 will be held on October 27, 2025. With healthcare and biopharma executives planning their schedules months in advance, early outreach is key to securing impactful meetings.
The attendee data available through Vendelux helps you align outreach with company initiatives and industry trends ahead of time, giving your team the context to show up prepared. Starting outreach in May or June allows room to build rapport, qualify interest, and claim time on calendars before they are fully booked.
With just one official day of programming, preparation beforehand becomes even more important. Leverage the months ahead to identify which contacts from the attendee list align with your campaign goals and prioritize scheduling high-value discussions.
What’s Included in the Biomarkers & Precision Medicine US 2025 Attendee List?
Vendelux provides visibility into executives anticipated to attend Biomarkers & Precision Medicine US 2025 through organizer-sourced data and predictive insights. Clients can upload target accounts to identify matches and prioritize them for action.
The enriched attendee list includes first and last name, job title, company name, company website, location (city, state, country), LinkedIn profile, verified email addresses, and direct phone numbers when available.
Where Is Biomarkers & Precision Medicine US 2025?
The event will be held at the Westin St. Francis San Francisco in San Francisco, California, United States.
When Is Biomarkers & Precision Medicine US 2025?
Biomarkers & Precision Medicine US 2025 is scheduled for October 27, 2025.
What Type of Event Is Biomarkers & Precision Medicine US 2025?
Biomarkers & Precision Medicine US 2025 is a senior-level industry conference focused on translational science, clinical development, and regulatory advancement in personalized medicine. The event features plenary sessions, interactive panels, and structured networking to help attendees explore collaborations, licensing opportunities, and investment prospects in the biomarker and precision diagnostics space.
How Many People Attend Biomarkers & Precision Medicine US 2025?
The event is expected to welcome over 300 attendees from across North America and Europe, with a strong concentration of director to VP-level executives from biopharma, biotech, diagnostics companies, and clinical organizations.
